Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

被引:321
作者
Udagawa, N
Takahashi, N
Yasuda, H
Mizuno, A
Itoh, K
Ueno, Y
Shinki, T
Gillespie, MT
Martin, TJ
Higashio, K
Suda, T
机构
[1] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan
[2] Snow Brand Milk Prod Co Ltd, Tochigi 3290512, Japan
[3] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1210/en.141.9.3478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoprotegerin (OPG), a soluble decoy receptor for receptor activator of nuclear factor-kappa B ligand (RANKL)/osteoclast differentiation factor, inhibits both differentiation and function of osteoclasts. We previously reported that OPG-deficient mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. In the present study, potential roles of OPG in osteoclast differentiation were examined using a mouse coculture system of calvarial osteoblasts and hone marrow cells prepared fi om OPG-deficient mice. in the absence of bone-resorbing factors, no osteoclasts were formed in cocultures of wild-type (+/+) or heterozygous (+/-) mouse-derived osteoblasts with bone marrow cells prepared from homozygous (-/-) mice. In contrast, homozygous (-/-) mouse-derived osteoblasts strongly supported osteoclast formation in the cocultures with homozygous (-/-) bone marrow cells, even in the absence of bone-resorbing factors. Addition of OPG to the cocultures with osteoblasts and bone marrow cells derived from homozygous (-/-) mice completely inhibited spontaneously occurring osteoclast formation. Adding 1 alpha,25-dihydroxyvitamin D-3 [1 alpha,25(OH)(2)D-3] to these cocultures significantly enhanced osteoclast differentiation. In addition, bone-resorbing activity in organ cultures of fetal long bones derived from homozygous (-/-) mice was markedly increased, irrespective of the presence and absence of bone-resorbing factors, in comparison with that from wild-type (+/+) mice. Osteoblasts prepared from homozygous (-/-), heterozygous (+/-), and wild-type (+/+) mice constitutively expressed similar levels of RANKL messenger RNA, which were equally increased by the treatment with 1 alpha,25(OH)(2)D-3. When homozygous (-/-) mouse-derived osteoblasts and hemopoietic cells were cocultured, hut direct contact between them was prevented, no osteoclasts were formed, even in the presence of 1 alpha,25(OH)(2)D-3 and macrophage colony-stimulating factor. These findings suggest that OPG produced by osteoblasts/stromal cells is a physiologically important regulator in osteoclast differentiation and function and that RANKL expressed by osteoblasts functions as a membrane-associated form.
引用
收藏
页码:3478 / 3484
页数:7
相关论文
共 35 条
[11]   OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis [J].
Kong, YY ;
Yoshida, H ;
Sarosi, I ;
Tan, HL ;
Timms, E ;
Capparelli, C ;
Morony, S ;
Oliveira-dos-Santos, AJ ;
Van, G ;
Itie, A ;
Khoo, W ;
Wakeham, A ;
Dunstan, CR ;
Lacey, DL ;
Mak, TW ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 397 (6717) :315-323
[12]  
Kotake S, 1998, ARTHRITIS RHEUM, V41, pS320
[13]   TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption [J].
Kwon, BS ;
Wang, SA ;
Udagawa, N ;
Haridas, V ;
Lee, ZH ;
Kim, KK ;
Oh, KO ;
Greene, J ;
Li, YL ;
Su, J ;
Gentz, R ;
Aggarwal, BB ;
Ni, J .
FASEB JOURNAL, 1998, 12 (10) :845-854
[14]   Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].
Lacey, DL ;
Timms, E ;
Tan, HL ;
Kelley, MJ ;
Dunstan, CR ;
Burgess, T ;
Elliott, R ;
Colombero, A ;
Elliott, G ;
Scully, S ;
Hsu, H ;
Sullivan, J ;
Hawkins, N ;
Davy, E ;
Capparelli, C ;
Eli, A ;
Qian, YX ;
Kaufman, S ;
Sarosi, I ;
Shalhoub, V ;
Senaldi, G ;
Guo, J ;
Delaney, J ;
Boyle, WJ .
CELL, 1998, 93 (02) :165-176
[15]   RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism [J].
Li, J ;
Sarosi, I ;
Yan, XQ ;
Morony, S ;
Capparelli, C ;
Tan, HL ;
McCabe, S ;
Elliott, R ;
Scully, S ;
Van, G ;
Kaufman, S ;
Juan, SC ;
Sun, Y ;
Tarpley, J ;
Martin, L ;
Christensen, K ;
McCabe, J ;
Kostenuik, P ;
Hsu, H ;
Fletcher, F ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1566-1571
[16]   Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival [J].
Lum, L ;
Wong, BR ;
Josien, R ;
Becherer, JD ;
Erdjument-Bromage, H ;
Schlöndorff, J ;
Tempst, P ;
Choi, Y ;
Blobel, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13613-13618
[17]   Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor osteoprotegerin [J].
Mizuno, A ;
Amizuka, N ;
Irie, K ;
Murakami, A ;
Fujise, N ;
Kanno, T ;
Sato, Y ;
Nakagawa, N ;
Yasuda, H ;
Mochizuki, S ;
Gomibuchi, T ;
Yano, K ;
Shima, N ;
Washida, N ;
Tsuda, E ;
Morinaga, T ;
Higashio, K ;
Ozawa, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :610-615
[18]   Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells [J].
Murakami, T ;
Yamamoto, M ;
Yamamoto, M ;
Ono, K ;
Nishikawa, M ;
Nagata, N ;
Motoyoshi, K ;
Akatsu, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (03) :747-752
[19]   RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis [J].
Nakagawa, N ;
Kinosaki, M ;
Yamaguchi, K ;
Shima, N ;
Yasuda, H ;
Yano, K ;
Morinaga, T ;
Higashio, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) :395-400
[20]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319